---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-047071"
form_type: "8-K"
ticker: "ANGO"
cik: "0001275187"
company_name: "ANGIODYNAMICS INC"
filed_at: "2024-11-15T23:59:59+00:00"
generated_at: "2026-05-29T23:37:50.851888+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# AngioDynamics shareholders approve all proposals at 2024 annual meeting including equity plan amendment

## Summary
- Elected three Class III directors: Burgess, Johnson, Licitra each with >24.8M votes for, 5.99M broker non-votes.
- Ratified Deloitte & Touche as FY2025 auditor with 34.1M for, 155k against, 16.5k abstain.
- Advisory approval of exec compensation: 26.0M for, 1.25M against, 1.04M abstain, 5.99M broker non-votes.
- Approved amended 2020 Equity Incentive Plan increasing share reserve: 23.2M for, 5.06M against, 35k abstain, 5.99M broker non-votes.

## SEC filing metadata
- accession: 0001140361-24-047071
- form_type: 8-K
- ticker: ANGO
- cik: 0001275187
- company_name: ANGIODYNAMICS INC
- filed_at: 2024-11-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1275187/000114036124047071/0001140361-24-047071-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1275187/000114036124047071/ef20038737_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-047071
- JSON: https://secwatch.observer/filing/0001140361-24-047071.json
- Plain text: https://secwatch.observer/filing/0001140361-24-047071.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.